NCT03867799View on ClinicalTrials.gov

iSCORE: Immunotherapy Sequencing in COlon and REctal Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

October 21, 2022

Study Completion Date

September 30, 2024

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Nivolumab

Immunotherapy

Trial Locations (1)

SW3 6JJ

The Royal Marsden NHS Foundation Trust, London

All Listed Sponsors
lead

Royal Marsden NHS Foundation Trust

OTHER

NCT03867799 - iSCORE: Immunotherapy Sequencing in COlon and REctal Cancer | Biotech Hunter | Biotech Hunter